Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns

globenewswire.com
APLS BLRX LLY NVO TAK

Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline

businesswire.com
LLY

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

globenewswire.com
NVDA LLY

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

globenewswire.com
NVDA LLY TMO AMGN

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

globenewswire.com
BIIB LLY TECH

HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options

prnewswire.com
LLY

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

globenewswire.com
LLY NVO

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

accessnewswire.com
NVO LLY

Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures

globenewswire.com
JNJ LLY

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

businesswire.com
LLY